Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jaime A. Davidson. (2015) Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy. Postgraduate Medicine 127:8, pages 827-841.
Read now
Read now
John Gerich. (2013) Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies. International Journal of General Medicine 6, pages 877-895.
Read now
Read now
James Malone, Michael Trautmann, Ken Wilhelm, Kristin Taylor & David M Kendall. (2009) Exenatide once weekly for the treatment of type 2 diabetes. Expert Opinion on Investigational Drugs 18:3, pages 359-367.
Read now
Read now
Stephen Jones, Marian Benroubi, Conxa Castell, Albert Goday, Andreas Liebl, Louise Timlin, Claudia Nicolay, Alexander Simpson & Aodan Tynan. (2009) Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*. Current Medical Research and Opinion 25:3, pages 691-700.
Read now
Read now
Ali Benhaddou-Andaloussi, Louis C. Martineau, Danielle Spoor, Tri Vuong, Charles Leduc, Erik Joly, Andrew Burt, Bouchra Meddah, Abdellatif Settaf, John T. Arnason, Marc Prentki & Pierre S. Haddad. (2008) Antidiabetic Activity of Nigella sativa. Seed Extract in Cultured Pancreatic β-cells, Skeletal Muscle Cells, and Adipocytes. Pharmaceutical Biology 46:1-2, pages 96-104.
Read now
Read now
Articles from other publishers (42)
Myungjin Kang, Henrique Smanio Neto, André Antonio Pelegrine, Cecilia Pedroso Turssi, Juliana Trindade Clemente-Napimoga & Marcelo Henrique Napimoga. (2023) Survival rate of dental implants installed by postgraduate students attending an implantology program in Brazil: A 52-month retrospective analysis. Frontiers in Dental Medicine 4.
Crossref
Crossref
Mădălin Dorel Țap, Anamaria-Cătălina Radu, Dodu Gheorghe Petrescu, Cristina Stanciu (Neculau)Raluca-Cristina Răducu. (2023) The Main Decisional Factors That Influence the Decision of the Patients Suffering from Diabetes to Have Dental Implants Using New Technologies after the COVID-19 Pandemic Period. Sustainability 15:3, pages 2053.
Crossref
Crossref
Yasmin Al Ansari, Halime Shahwan & Bruno Ramos Chrcanovic. (2022) Diabetes Mellitus and Dental Implants: A Systematic Review and Meta-Analysis. Materials 15:9, pages 3227.
Crossref
Crossref
Abba Talba Mahamad, David Miaffo, Sylviane Laure Poualeu Kamani, Oumar Mahamat, Albert Kamanyi & Sylvie Léa Wansi Ngnokam. (2020) Glucose, lipid and oxidative stress lowering activity of the aqueous extract from leafy stems of Cissus polyantha Gilg & Brandt in dexamethasone-induced hyperglycemia in rats. Journal of Diabetes & Metabolic Disorders 19:2, pages 1527-1535.
Crossref
Crossref
Thomas W. Oates & Namita Khandelwal. 2020. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
451
471
.
Raffaele Simeoli & Alessandra Fierabracci. (2019) Insights into the Role of MicroRNAs in the Onset and Development of Diabetic Neuropathy. International Journal of Molecular Sciences 20:18, pages 4627.
Crossref
Crossref
Thomas W. Oates & Namita Khandelwal. 2019. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
1
21
.
Suya Du, Huirong Liu, Tiantian Lei, Xiaofang Xie, Hailian Wang, Xia He, Rongsheng Tong & Yi Wang. (2018) Mangiferin: An effective therapeutic agent against several disorders (Review). Molecular Medicine Reports.
Crossref
Crossref
Hua Shu, Juming Lu, Puhong Zhang, Dongshan Zhu, Xian Li, Jiachao Ji, Fang Zhao & Linong Ji. (2018)
Clinical characteristics of type 2 diabetes patients with discordance between
HbA
1c
and fasting plasma glucose in the real world:
A
n analysis of the
ORBIT
study
. Diabetes/Metabolism Research and Reviews 34:4.
Crossref
Crossref
Parnika Goyal, Dimpy Rani & Renu Chadha. (2017) Crystal Engineering: A Remedy To Tailor the Biopharmaceutical Aspects of Glibenclamide. Crystal Growth & Design 18:1, pages 105-118.
Crossref
Crossref
Thomas W. Oates & Namita Khandelwal. 2018. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
451
471
.
Thomas W. Oates & Namita Khandelwal. 2018. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
1
21
.
Bruna Ghiraldini, Alexandre Conte, Renato Correa Casarin, Marcio Zaffalon Casati, Suzana Peres Pimentel, Fabiano Ribeiro Cirano & Fernanda Vieira Ribeiro. (2016) Influence of Glycemic Control on Peri-Implant Bone Healing: 12-Month Outcomes of Local Release of Bone-Related Factors and Implant Stabilization in Type 2 Diabetics. Clinical Implant Dentistry and Related Research 18:4, pages 801-809.
Crossref
Crossref
Raluca-Iulia Juncar, Mihai Juncar, Florin-Onişor Gligor & Amorin-Remus Popa. (2015) Effect of Masticatory Forces Transmitted by Dental Implants on the Mandibular Bone of Patients with Type 2 Diabetes Mellitus. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 22:4, pages 419-424.
Crossref
Crossref
B.R. Chrcanovic, T. Albrektsson & A. Wennerberg. (2014) Diabetes and Oral Implant Failure. Journal of Dental Research 93:9, pages 859-867.
Crossref
Crossref
Malene Hornbak, Kristine Højgaard Allin, Majken Linnemann Jensen, Cathrine Juel Lau, Daniel Witte, Marit Eika Jørgensen, Annelli Sandbæk, Torsten Lauritzen, Åsa Andersson, Oluf Pedersen & Torben Hansen. (2014) A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes. PLoS ONE 9:8, pages e104837.
Crossref
Crossref
Shih-Yin Chen, Yuan-Chi Lee, Veronica Alas, Mallik Greene & Diana Brixner. (2014) Outcomes Associated with Nonconcordance to National Kidney Foundation Guideline Recommendations for Oral Antidiabetic Drug Treatments in Patients with Concomitant Type 2 Diabetes and Chronic Kidney Disease. Endocrine Practice 20:3, pages 221-231.
Crossref
Crossref
Rajesh Peddaiahgari, Ayoade O. Adeyemi, Jamie C. Barner, Debra A. Lopez & Jason R. Jokerst. (2014) A Retrospective Observational Analysis of Clinical Outcomes before and after the Publication of the AACE/ACE Guidelines. International Journal of Clinical Medicine 05:12, pages 717-723.
Crossref
Crossref
Yiping Mao, Ramkumar Mohan, Shungang Zhang & Xiaoqing Tang. (2013) MicroRNAs as pharmacological targets in diabetes. Pharmacological Research 75, pages 37-47.
Crossref
Crossref
Thomas W. Oates, Guy Huynh‐Ba, Adriana Vargas, Peggy Alexander & Jocelyne Feine. (2011) A critical review of diabetes, glycemic control, and dental implant therapy. Clinical Oral Implants Research 24:2, pages 117-127.
Crossref
Crossref
Aditya Arya, Chung Yeng Looi, Shiau Chuen Cheah, Mohd Rais Mustafa & Mustafa Ali Mohd. (2012) Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats. Journal of Ethnopharmacology 144:1, pages 22-32.
Crossref
Crossref
C. Miele & F. Beguinot. (2012) New expectations from the well-known medicinal properties of Arctium lappa. Diabetologia 55:5, pages 1244-1246.
Crossref
Crossref
Mohammadreza Bozorgmanesh, Farzad Hadaegh, Farhad Sheikholeslami, Arash Ghanbarian & Fereidoun Azizi. (2012) Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality. Cardiovascular Diabetology 11:1, pages 69.
Crossref
Crossref
Arthur L.M. SwislockiJoy L. MeierSallie M. NajeraRobert H. Noth. (2011) Long-Term Maintenance of Glucose Control in Veterans with Type 2 Diabetes Mellitus Using Oral Agents. Metabolic Syndrome and Related Disorders 9:6, pages 469-473.
Crossref
Crossref
X. Zhang, Z. Wang, Y. Huang & J. Wang. (2011) Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice. Diabetes, Obesity and Metabolism 13:4, pages 337-347.
Crossref
Crossref
Anne Flint, Khalil Nazzal, Pawel Jagielski, Charlotte Hindsberger & Milan Zdravkovic. (2010) Influence of hepatic impairment on pharmacokinetics of the human GLP‐1 analogue, liraglutide. British Journal of Clinical Pharmacology 70:6, pages 807-814.
Crossref
Crossref
Jennifer H. ChoiJeffrey M. GimbleGordana Vunjak-NovakovicDavid L. Kaplan. (2010) Effects of Hyperinsulinemia on Lipolytic Function of Three-Dimensional Adipocyte/Endothelial Co-Cultures. Tissue Engineering Part C: Methods 16:5, pages 1157-1165.
Crossref
Crossref
Burton M. Wice, Songyan Wang, Dan L. Crimmins, Kelly A. Diggs-Andrews, Matthew C. Althage, Eric L. Ford, Hung Tran, Matthew Ohlendorf, Terry A. Griest, Qiuling Wang, Simon J. Fisher, Jack H. Ladenson & Kenneth S. Polonsky. (2010) Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism. Journal of Biological Chemistry 285:26, pages 19842-19853.
Crossref
Crossref
Kyriaki Gerozissis. 2010. Diabetes, Insulin and Alzheimer's Disease. Diabetes, Insulin and Alzheimer's Disease
21
42
.
Parag P Shah, Lauren E Hutchinson & Sham S Kakar. (2009) Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer. Journal of Ovarian Research 2:1.
Crossref
Crossref
Darleen A. Sandoval, Silvana Obici & Randy J. Seeley. (2009) Targeting the CNS to treat type 2 diabetes. Nature Reviews Drug Discovery 8:5, pages 386-398.
Crossref
Crossref
Paras Kumar Mishra, Neetu Tyagi, Munish Kumar & Suresh C. Tyagi. (2009) MicroRNAs as a therapeutic target for cardiovascular diseases. Journal of Cellular and Molecular Medicine 13:4, pages 778-789.
Crossref
Crossref
J. Philippe & D. Raccah. (2009) Treating type 2 diabetes: how safe are current therapeutic agents?. International Journal of Clinical Practice 63:2, pages 321-332.
Crossref
Crossref
Julia M. Bottomley & Frank D. Raymond. (2009) Pharmaco-economic issues for diabetes therapy. Insulin 4:1, pages 32-60.
Crossref
Crossref
J. Rahier, Y. Guiot, R. M. Goebbels, C. Sempoux & J. C. Henquin. (2008) Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes, Obesity and Metabolism 10, pages 32-42.
Crossref
Crossref
Deena Waddleton, Weizhen Wu, Yue Feng, Chris Thompson, Michael Wu, Yun-Ping Zhou, Andrew Howard, Nancy Thornberry, Jing Li & Joseph A. Mancini. (2008) Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochemical Pharmacology 76:7, pages 884-893.
Crossref
Crossref
Jaime A. Davidson, Erika B. Parente & Jorge L. Gross. (2008) Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes. Arquivos Brasileiros de Endocrinologia & Metabologia 52:6, pages 1039-1049.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:2, pages 193-219.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:1, pages 79-111.
Crossref
Crossref
Mike Baxter. (2008) Treatment of type 2 diabetes: a structured management plan. Advances in Therapy 25:2, pages 106-114.
Crossref
Crossref
Lawrence P Reagan. (2007) Insulin signaling effects on memory and mood. Current Opinion in Pharmacology 7:6, pages 633-637.
Crossref
Crossref
Julia M. Bottomley & Frank D. Raymond. (2007) Pharmaco-economic issues for diabetes therapy. Best Practice & Research Clinical Endocrinology & Metabolism 21:4, pages 657-685.
Crossref
Crossref